Rockwell Medical (RMTI) Net Margin (2010 - 2026)
Rockwell Medical's (RMTI) quarterly Net Margin came in at 41.6% in Q1 2026, down 3184.0% YoY from 1.35% in Q1 2025, and down 362.21% on a QoQ basis from 9.0% in Q4 2025.
Rockwell Medical (RMTI) Net Margin (2010 - 2026) Analysis & Trends
Rockwell Medical (RMTI) has 17 years of Net Margin data on file, last reported at 41.6% in Q1 2026.
- Quarterly Net Margin fell 3184.0% year-over-year to 41.6% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 20.0% (down 1939.0% YoY) and the FY2025 annual result came in at 16.39%, up 6693.0% from the prior year.
- Net Margin slipped to 41.6% in Q1 2026, from 9.0% in the prior quarter.
- In the past five years, Net Margin ranged from a high of 5.36% in Q3 2024 to a low of 44.44% in Q1 2022.
- A 5-year average of 14.14% and a median of 9.76% in 2025 frame the typical range for Net Margin.
- Annual changes were most pronounced in 2022 — Net Margin surged 4503 bps — and 2026, when it tumbled 3184 bps.
- Tracing RMTI's Net Margin over 5 years: stood at 9.82% in 2022, then advanced by 26 bps to 7.3% in 2023, then jumped by 79 bps to 1.51% in 2024, then slumped by 497 bps to 9.0% in 2025, then sank by 362 bps to 41.6% in 2026.
- The last three Net Margin figures came in at 41.6% (Q1 2026), 9.0% (Q4 2025), and 13.07% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | -13.91% |
| 3 | Zoetis | 31.53 Bn | 29.85 Bn | 1.05 Bn | 35.09% |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 9.28% |
| 5 | United Therapeutics | 22.13 Bn | 19.47 Bn | 683.80 Mn | 42.51% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -3.16% |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 15.06% |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 3.95% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Rockwell Medical | 29.97 Mn | 5.17 Mn | 3.24 Mn | -7.32% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -35.53% |
| Mar 31, 2026 | -41.60% |
| Dec 31, 2025 | -9.00% |
| Sep 30, 2025 | -13.07% |
| Jun 30, 2025 | -16.15% |
| Mar 31, 2025 | -9.76% |
| Dec 31, 2024 | -1.51% |
| Sep 30, 2024 | 5.36% |
| Jun 30, 2024 | 0.38% |
| Mar 31, 2024 | -7.66% |
| Dec 31, 2023 | -7.30% |
| Sep 30, 2023 | -9.01% |
| Jun 30, 2023 | -18.74% |
| Mar 31, 2023 | -9.09% |
| Dec 31, 2022 | -9.82% |
| Sep 30, 2022 | -22.42% |
| Jun 30, 2022 | -26.59% |
| Mar 31, 2022 | -44.44% |
| Dec 31, 2021 | -54.85% |
| Sep 30, 2021 | -47.42% |